Physician profile
Ebenezer T Oni
NPI 1215325238
$5,216.86
in general payments reported to CMS, 2019-2025
21 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $490 · 2021: $1,409 · 2022: $1,514 · 2023: $645 · 2024: $295 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264 · Education: $19.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.50 |
| Education | $19.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,608.96 | 2019-2023 | Optis, Pressurewire, Dragonfly Opstar |
| Astellas Pharma US INC | $478.95 | 2019-2021 | |
| Pfizer INC. | $390.62 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $383.60 | 2021-2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $173.06 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $164.16 | 2019-2024 | Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.34 | 2019-2025 | Lifevest |
| Amgen INC. | $138.72 | 2019-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $136.56 | 2019-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.75 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $103.37 | 2021-2025 | |
| Boston Scientific Corporation | $101.57 | 2021-2023 | Lux-Dx Insertable Cardiac Monitor |
| Novo Nordisk INC | $55.12 | 2023 | Rybelsus, Ozempic |
| Daiichi Sankyo INC. | $51.80 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.68 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $29.34 | 2025 | |
| Medicomp INC | $23.65 | 2024 | Telepatch Cardiac Monitor |
| Kiniksa Pharmaceuticals, LTD. | $20.03 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $16.61 | 2020 | |
| Abiomed | $16.42 | 2020 | |
| Merck Sharp & Dohme LLC | $14.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebenezer Oni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.